Innovation Marks Steady Growth of Asian Biotech

The conversation about outsourcing to Asia has changed from cost reduction to opportunity. The recent BIOCOM “CalAsia Conference” in San Diego focused on strategies biotech companies can use to leverage the strengths of Asian biotech opportunities. Presenters agreed that Asia is becoming increasingly innovative as it gains experience and an infrastructure to support the biotech industry. Consequently, the work performed in Asia is moving up the value chain.

Steven Burrill, CEO of Burrill & Company, suggested that Asian nation’s strengths in information technology—specifically silicon chips and semiconductors—will catapult them to the fore of healthcare innovation. “In the Asia-Pacific region, they’re building tomorrow’s healthcare system today,” Burrill said. He characterized the future of biotech as “Silicon Valley meets physics,” leading to greater opportunities. 

... more text ...

Notice: The copyright of this article is owned by another publisher, please visit the following website link for the full text of the article. The full access to the article is under the control of its publisher. Viewers who cannot access the article online can contact us at croasia@croasia.net for further information.

Click here to access the full article

By clicking on the above link, you will leave CROAsia.net. If you wish to return to this website, please click "Back" button or log onto CROAsia.net again.